UnitedHealth Group Joins Zacks Strong Buy List Amid Undervalued Narrative

UnitedHealth Group (UNH) has been added to the Zacks Rank #1 (Strong Buy) list after an increase in the Zacks Consensus Estimate for current year earnings.

The company's short-term share price performance has been weak, with a 30-day return down 9.55%, but its year-to-date return is 15.97% and its one-year total shareholder return is 30.30%, indicating positive overall momentum.

According to the most popular narrative, UNH is undervalued by around 17.9%, with a fair value estimate of $475.23 compared to its last closing price of $390.11.

The company faces risks such as execution on the new CMS risk model and potential policy or funding shifts that could pressure Medicare Advantage margins.